Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02333890Phase 2Unknown
A Phase 2 trial of chloroquine in invasive breast cancer, sponsored by Ottawa Hospital Research Institute. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02333890.